204 results on '"Vesuna, Farhad"'
Search Results
2. Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype
3. Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer
4. The Transcription Factor Encyclopedia
5. Supplementary Figures 1 - 11 from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis
6. Data from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis
7. Supplementary Table 2 from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis
8. Supplementary Table 1 from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis
9. Data from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
10. Supplementary Table 2 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
11. Supplementary Figure 1 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
12. Supplementary Table 1 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
13. Supplementary Figure 4 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
14. Supplementary Figure 3 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
15. Supplementary Figure Legends from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
16. Supplementary Figure 5 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
17. Supplementary Figure 2 from RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
18. Supplementary Figure 2 from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer
19. Supplementary Figure 1 from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer
20. Supplementary Figure Legends from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer
21. Data from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer
22. Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells
23. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer
24. Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype
25. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
26. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
27. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
28. Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer
29. Targeting host DEAD-box RNA helicase DDX3X for treating viral infections
30. Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity
31. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
32. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
33. Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation
34. Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation
35. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
36. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
37. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
38. Abstract B41: BP1 is an important biomarker in breast cancer
39. Abstract 3338: BP1 induces an epithelial to mesenchymal transition in breast cancer cells by modulating the Twist/IL6 pathway
40. Abstract 5874: Targeting DDX3 in medulloblastoma by RK-33
41. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
42. Role of DDX3 in the pathogenesis of inflammatory bowel disease
43. Genomic pathways modulated by Twist in breast cancer
44. Role of DDX3 in the pathogenesis of inflammatory bowel disease
45. Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
46. Genomic pathways modulated by Twist in breast cancer
47. Role of DDX3 in the pathogenesis of inflammatory bowel disease
48. Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
49. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer
50. Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.